nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—GPCR ligand binding—GRM5—epilepsy syndrome	0.000868	0.00342	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CHRM3—epilepsy syndrome	0.000868	0.00342	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	0.000867	0.00342	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ACKR4—epilepsy syndrome	0.000857	0.00338	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.000854	0.00337	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.000854	0.00337	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	0.000851	0.00335	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.000832	0.00328	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	0.00083	0.00327	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR10—epilepsy syndrome	0.000819	0.00323	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CHRM2—epilepsy syndrome	0.000816	0.00322	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.000816	0.00322	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000816	0.00322	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000808	0.00319	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GABBR1—epilepsy syndrome	0.000794	0.00313	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.00079	0.00311	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.00079	0.00311	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000775	0.00306	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000775	0.00306	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.000773	0.00305	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HRH3—epilepsy syndrome	0.000761	0.003	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000752	0.00297	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000749	0.00295	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR10—epilepsy syndrome	0.000743	0.00293	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.000743	0.00293	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.000743	0.00293	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.000729	0.00287	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000716	0.00282	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000714	0.00281	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000711	0.0028	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR3—epilepsy syndrome	0.000707	0.00279	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—NPY—epilepsy syndrome	0.000689	0.00272	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000673	0.00265	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL2—epilepsy syndrome	0.000665	0.00262	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL3—epilepsy syndrome	0.000665	0.00262	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—OXT—epilepsy syndrome	0.000665	0.00262	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CRH—epilepsy syndrome	0.000665	0.00262	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM2—epilepsy syndrome	0.00065	0.00256	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000647	0.00255	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.000638	0.00252	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.00062	0.00245	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR9—epilepsy syndrome	0.00062	0.00245	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR8—epilepsy syndrome	0.00062	0.00245	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.00062	0.00245	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.00062	0.00245	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000608	0.0024	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000608	0.0024	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR2—epilepsy syndrome	0.000602	0.00237	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—SST—epilepsy syndrome	0.000602	0.00237	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000599	0.00236	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000597	0.00235	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	0.000594	0.00234	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000589	0.00232	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000588	0.00232	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.000587	0.00232	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	0.000581	0.00229	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRDM4—epilepsy syndrome	0.000579	0.00228	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000579	0.00228	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000577	0.00227	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000566	0.00223	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000566	0.00223	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR8—epilepsy syndrome	0.000563	0.00222	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000563	0.00222	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR9—epilepsy syndrome	0.000563	0.00222	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000563	0.00222	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000563	0.00222	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CNR1—epilepsy syndrome	0.000555	0.00219	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM3—epilepsy syndrome	0.000553	0.00218	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM4—epilepsy syndrome	0.000553	0.00218	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.00055	0.00217	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000542	0.00214	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR7—epilepsy syndrome	0.000542	0.00214	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000528	0.00208	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000528	0.00208	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000528	0.00208	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000528	0.00208	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM8—epilepsy syndrome	0.000524	0.00207	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000509	0.00201	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ACKR4—epilepsy syndrome	0.000507	0.002	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—OPRD1—epilepsy syndrome	0.0005	0.00197	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GNAO1—epilepsy syndrome	0.0005	0.00197	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000498	0.00196	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GAL—epilepsy syndrome	0.000496	0.00196	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.00049	0.00193	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GRM5—epilepsy syndrome	0.00049	0.00193	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000479	0.00189	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM1—epilepsy syndrome	0.000479	0.00189	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR7—epilepsy syndrome	0.000479	0.00189	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PDYN—epilepsy syndrome	0.000479	0.00189	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000473	0.00186	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000461	0.00182	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000461	0.00182	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR5—epilepsy syndrome	0.000458	0.00181	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR4—epilepsy syndrome	0.000458	0.00181	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AVP—epilepsy syndrome	0.000456	0.0018	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GAL—epilepsy syndrome	0.00045	0.00178	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000449	0.00177	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GRM5—epilepsy syndrome	0.000445	0.00176	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000445	0.00176	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR10—epilepsy syndrome	0.000439	0.00173	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HRH3—epilepsy syndrome	0.00043	0.0017	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000427	0.00168	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000423	0.00167	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000419	0.00165	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000419	0.00165	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000419	0.00165	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000407	0.00161	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR3—epilepsy syndrome	0.0004	0.00158	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000398	0.00157	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HRH3—epilepsy syndrome	0.000391	0.00154	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—NPY—epilepsy syndrome	0.00039	0.00154	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000389	0.00153	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCR5—epilepsy syndrome	0.000388	0.00153	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000384	0.00152	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRM2—epilepsy syndrome	0.000384	0.00151	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000379	0.0015	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—OXT—epilepsy syndrome	0.000376	0.00148	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000376	0.00148	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CRH—epilepsy syndrome	0.000376	0.00148	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCR3—epilepsy syndrome	0.000363	0.00143	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGT—epilepsy syndrome	0.00036	0.00142	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPY—epilepsy syndrome	0.000354	0.00139	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR3—epilepsy syndrome	0.000347	0.00137	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—OXT—epilepsy syndrome	0.000341	0.00135	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CRH—epilepsy syndrome	0.000341	0.00135	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000341	0.00135	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL3—epilepsy syndrome	0.000341	0.00135	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCR2—epilepsy syndrome	0.00034	0.00134	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—SST—epilepsy syndrome	0.00034	0.00134	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.00034	0.00134	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NPY2R—epilepsy syndrome	0.000333	0.00131	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR1—epilepsy syndrome	0.000333	0.00131	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR8—epilepsy syndrome	0.000333	0.00131	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR9—epilepsy syndrome	0.000333	0.00131	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000333	0.00131	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000333	0.00131	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRM4—epilepsy syndrome	0.000326	0.00129	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRM3—epilepsy syndrome	0.000326	0.00129	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SSTR2—epilepsy syndrome	0.00032	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DUSP4—epilepsy syndrome	0.00032	0.00126	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.00032	0.00126	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.00032	0.00126	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000314	0.00124	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000313	0.00123	CbGpPWpGaD
Travoprost—Dermatitis—Midazolam—epilepsy syndrome	0.000311	0.000417	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GRM8—epilepsy syndrome	0.000309	0.00122	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PGF—epilepsy syndrome	0.000309	0.00122	CbGpPWpGaD
Travoprost—Discomfort—Valproic Acid—epilepsy syndrome	0.000309	0.000414	CcSEcCtD
Travoprost—Headache—Midazolam—epilepsy syndrome	0.000309	0.000414	CcSEcCtD
Travoprost—Pruritus—Felbamate—epilepsy syndrome	0.000309	0.000414	CcSEcCtD
Travoprost—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000309	0.000414	CcSEcCtD
Travoprost—Diarrhoea—Diazepam—epilepsy syndrome	0.000309	0.000414	CcSEcCtD
Travoprost—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000309	0.000414	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCR2—epilepsy syndrome	0.000309	0.00122	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—SST—epilepsy syndrome	0.000309	0.00122	CbGpPWpGaD
Travoprost—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000308	0.000413	CcSEcCtD
Travoprost—Sinusitis—Topiramate—epilepsy syndrome	0.000308	0.000413	CcSEcCtD
Travoprost—Rash—Levetiracetam—epilepsy syndrome	0.000307	0.000412	CcSEcCtD
Travoprost—Dermatitis—Levetiracetam—epilepsy syndrome	0.000307	0.000411	CcSEcCtD
Travoprost—Asthenia—Zonisamide—epilepsy syndrome	0.000307	0.000411	CcSEcCtD
Travoprost—Mental disorder—Gabapentin—epilepsy syndrome	0.000307	0.000411	CcSEcCtD
Travoprost—Dry mouth—Valproic Acid—epilepsy syndrome	0.000306	0.00041	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—HTR7—epilepsy syndrome	0.000306	0.00121	CbGpPWpGaD
Travoprost—Headache—Levetiracetam—epilepsy syndrome	0.000305	0.000409	CcSEcCtD
Travoprost—Erythema—Gabapentin—epilepsy syndrome	0.000305	0.000408	CcSEcCtD
Travoprost—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000304	0.000407	CcSEcCtD
Travoprost—Dizziness—Vigabatrin—epilepsy syndrome	0.000303	0.000406	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—POMC—epilepsy syndrome	0.000303	0.00119	CbGpPWpGaD
Travoprost—Pruritus—Zonisamide—epilepsy syndrome	0.000303	0.000405	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000302	0.00119	CbGpPWpGaD
Travoprost—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000302	0.000404	CcSEcCtD
Travoprost—Oedema—Valproic Acid—epilepsy syndrome	0.0003	0.000402	CcSEcCtD
Travoprost—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.0003	0.000402	CcSEcCtD
Travoprost—Bradycardia—Topiramate—epilepsy syndrome	0.0003	0.000402	CcSEcCtD
Travoprost—Malaise—Pregabalin—epilepsy syndrome	0.0003	0.000402	CcSEcCtD
Travoprost—Nausea—Propofol—epilepsy syndrome	0.0003	0.000401	CcSEcCtD
Travoprost—Diarrhoea—Felbamate—epilepsy syndrome	0.000299	0.0004	CcSEcCtD
Travoprost—Vertigo—Pregabalin—epilepsy syndrome	0.000299	0.0004	CcSEcCtD
Travoprost—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000299	0.0004	CcSEcCtD
Travoprost—Dysgeusia—Gabapentin—epilepsy syndrome	0.000299	0.0004	CcSEcCtD
Travoprost—Dizziness—Diazepam—epilepsy syndrome	0.000298	0.0004	CcSEcCtD
Travoprost—Infection—Valproic Acid—epilepsy syndrome	0.000298	0.000399	CcSEcCtD
Travoprost—Rash—Fosphenytoin—epilepsy syndrome	0.000297	0.000397	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL2—epilepsy syndrome	0.000296	0.00117	CbGpPWpGaD
Travoprost—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000296	0.000397	CcSEcCtD
Travoprost—Asthenia—Clonazepam—epilepsy syndrome	0.000296	0.000396	CcSEcCtD
Travoprost—Rhinitis—Topiramate—epilepsy syndrome	0.000295	0.000396	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—OPRD1—epilepsy syndrome	0.000295	0.00116	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GNAO1—epilepsy syndrome	0.000295	0.00116	CbGpPWpGaD
Travoprost—Back pain—Gabapentin—epilepsy syndrome	0.000295	0.000395	CcSEcCtD
Travoprost—Headache—Fosphenytoin—epilepsy syndrome	0.000295	0.000395	CcSEcCtD
Travoprost—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000294	0.000394	CcSEcCtD
Travoprost—Palpitations—Pregabalin—epilepsy syndrome	0.000294	0.000394	CcSEcCtD
Travoprost—Asthenia—Phenytoin—epilepsy syndrome	0.000294	0.000394	CcSEcCtD
Travoprost—Nausea—Midazolam—epilepsy syndrome	0.000293	0.000393	CcSEcCtD
Travoprost—Tachycardia—Valproic Acid—epilepsy syndrome	0.000293	0.000392	CcSEcCtD
Travoprost—Diarrhoea—Zonisamide—epilepsy syndrome	0.000293	0.000392	CcSEcCtD
Travoprost—Pharyngitis—Topiramate—epilepsy syndrome	0.000292	0.000392	CcSEcCtD
Travoprost—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000292	0.000391	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000292	0.00115	CbGpPWpGaD
Travoprost—Pruritus—Clonazepam—epilepsy syndrome	0.000292	0.000391	CcSEcCtD
Travoprost—Skin disorder—Valproic Acid—epilepsy syndrome	0.000291	0.000391	CcSEcCtD
Travoprost—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000291	0.00039	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CXCL12—epilepsy syndrome	0.00029	0.00114	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.00029	0.00114	CbGpPWpGaD
Travoprost—Cough—Pregabalin—epilepsy syndrome	0.00029	0.000389	CcSEcCtD
Travoprost—Pruritus—Phenytoin—epilepsy syndrome	0.00029	0.000388	CcSEcCtD
Travoprost—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000289	0.000388	CcSEcCtD
Travoprost—Nausea—Levetiracetam—epilepsy syndrome	0.000289	0.000388	CcSEcCtD
Travoprost—Rash—Vigabatrin—epilepsy syndrome	0.000289	0.000387	CcSEcCtD
Travoprost—Dizziness—Felbamate—epilepsy syndrome	0.000289	0.000387	CcSEcCtD
Travoprost—Dermatitis—Vigabatrin—epilepsy syndrome	0.000289	0.000387	CcSEcCtD
Travoprost—Urethral disorder—Topiramate—epilepsy syndrome	0.000289	0.000387	CcSEcCtD
Travoprost—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000288	0.000386	CcSEcCtD
Travoprost—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000288	0.000386	CcSEcCtD
Travoprost—Vision blurred—Gabapentin—epilepsy syndrome	0.000287	0.000385	CcSEcCtD
Travoprost—Headache—Vigabatrin—epilepsy syndrome	0.000287	0.000385	CcSEcCtD
Travoprost—Hypertension—Pregabalin—epilepsy syndrome	0.000287	0.000385	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CNR1—epilepsy syndrome	0.000285	0.00112	CbGpPWpGaD
Travoprost—Rash—Diazepam—epilepsy syndrome	0.000285	0.000381	CcSEcCtD
Travoprost—Dermatitis—Diazepam—epilepsy syndrome	0.000284	0.000381	CcSEcCtD
Travoprost—Visual impairment—Topiramate—epilepsy syndrome	0.000284	0.00038	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000284	0.00112	CbGpPWpGaD
Travoprost—Myalgia—Pregabalin—epilepsy syndrome	0.000283	0.000379	CcSEcCtD
Travoprost—Arthralgia—Pregabalin—epilepsy syndrome	0.000283	0.000379	CcSEcCtD
Travoprost—Chest pain—Pregabalin—epilepsy syndrome	0.000283	0.000379	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CHRM1—epilepsy syndrome	0.000283	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRM1—epilepsy syndrome	0.000283	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PDYN—epilepsy syndrome	0.000283	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR7—epilepsy syndrome	0.000283	0.00112	CbGpPWpGaD
Travoprost—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000283	0.000379	CcSEcCtD
Travoprost—Dizziness—Zonisamide—epilepsy syndrome	0.000283	0.000379	CcSEcCtD
Travoprost—Headache—Diazepam—epilepsy syndrome	0.000283	0.000379	CcSEcCtD
Travoprost—Anxiety—Pregabalin—epilepsy syndrome	0.000282	0.000378	CcSEcCtD
Travoprost—Diarrhoea—Clonazepam—epilepsy syndrome	0.000282	0.000378	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000281	0.000377	CcSEcCtD
Travoprost—Hypotension—Valproic Acid—epilepsy syndrome	0.00028	0.000376	CcSEcCtD
Travoprost—Asthenia—Carbamazepine—epilepsy syndrome	0.00028	0.000376	CcSEcCtD
Travoprost—Diarrhoea—Phenytoin—epilepsy syndrome	0.00028	0.000375	CcSEcCtD
Travoprost—Discomfort—Pregabalin—epilepsy syndrome	0.00028	0.000375	CcSEcCtD
Travoprost—Nausea—Fosphenytoin—epilepsy syndrome	0.000279	0.000374	CcSEcCtD
Travoprost—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000279	0.000373	CcSEcCtD
Travoprost—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000278	0.000373	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HTR7—epilepsy syndrome	0.000278	0.0011	CbGpPWpGaD
Travoprost—Dry mouth—Pregabalin—epilepsy syndrome	0.000277	0.000371	CcSEcCtD
Travoprost—Pruritus—Carbamazepine—epilepsy syndrome	0.000276	0.00037	CcSEcCtD
Travoprost—Rash—Felbamate—epilepsy syndrome	0.000275	0.000369	CcSEcCtD
Travoprost—Eye disorder—Topiramate—epilepsy syndrome	0.000275	0.000369	CcSEcCtD
Travoprost—Dermatitis—Felbamate—epilepsy syndrome	0.000275	0.000369	CcSEcCtD
Travoprost—Malaise—Gabapentin—epilepsy syndrome	0.000275	0.000368	CcSEcCtD
Travoprost—Tinnitus—Topiramate—epilepsy syndrome	0.000275	0.000368	CcSEcCtD
Travoprost—Vertigo—Gabapentin—epilepsy syndrome	0.000274	0.000367	CcSEcCtD
Travoprost—Headache—Felbamate—epilepsy syndrome	0.000274	0.000367	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000273	0.000366	CcSEcCtD
Travoprost—Cardiac disorder—Topiramate—epilepsy syndrome	0.000273	0.000366	CcSEcCtD
Travoprost—Dizziness—Clonazepam—epilepsy syndrome	0.000273	0.000365	CcSEcCtD
Travoprost—Nausea—Vigabatrin—epilepsy syndrome	0.000272	0.000365	CcSEcCtD
Travoprost—Oedema—Pregabalin—epilepsy syndrome	0.000271	0.000364	CcSEcCtD
Travoprost—Asthenia—Lamotrigine—epilepsy syndrome	0.000271	0.000363	CcSEcCtD
Travoprost—Dizziness—Phenytoin—epilepsy syndrome	0.000271	0.000363	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HBEGF—epilepsy syndrome	0.00027	0.00106	CbGpPWpGaD
Travoprost—Rash—Zonisamide—epilepsy syndrome	0.00027	0.000361	CcSEcCtD
Travoprost—Infection—Pregabalin—epilepsy syndrome	0.00027	0.000361	CcSEcCtD
Travoprost—Palpitations—Gabapentin—epilepsy syndrome	0.000269	0.000361	CcSEcCtD
Travoprost—Dermatitis—Zonisamide—epilepsy syndrome	0.000269	0.000361	CcSEcCtD
Travoprost—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000269	0.000361	CcSEcCtD
Travoprost—Nausea—Diazepam—epilepsy syndrome	0.000268	0.000359	CcSEcCtD
Travoprost—Headache—Zonisamide—epilepsy syndrome	0.000268	0.000359	CcSEcCtD
Travoprost—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000268	0.000358	CcSEcCtD
Travoprost—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000267	0.000358	CcSEcCtD
Travoprost—Angiopathy—Topiramate—epilepsy syndrome	0.000267	0.000358	CcSEcCtD
Travoprost—Pruritus—Lamotrigine—epilepsy syndrome	0.000267	0.000358	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000266	0.00105	CbGpPWpGaD
Travoprost—Immune system disorder—Topiramate—epilepsy syndrome	0.000266	0.000357	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GAL—epilepsy syndrome	0.000266	0.00105	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GFAP—epilepsy syndrome	0.000266	0.00105	CbGpPWpGaD
Travoprost—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000266	0.000356	CcSEcCtD
Travoprost—Cough—Gabapentin—epilepsy syndrome	0.000266	0.000356	CcSEcCtD
Travoprost—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000266	0.000356	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AKT3—epilepsy syndrome	0.000265	0.00104	CbGpPWpGaD
Travoprost—Tachycardia—Pregabalin—epilepsy syndrome	0.000265	0.000355	CcSEcCtD
Travoprost—Dyspepsia—Valproic Acid—epilepsy syndrome	0.000264	0.000354	CcSEcCtD
Travoprost—Skin disorder—Pregabalin—epilepsy syndrome	0.000264	0.000353	CcSEcCtD
Travoprost—Hypertension—Gabapentin—epilepsy syndrome	0.000263	0.000353	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CASP2—epilepsy syndrome	0.000263	0.00104	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CHRM3—epilepsy syndrome	0.000263	0.00104	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GRM5—epilepsy syndrome	0.000263	0.00104	CbGpPWpGaD
Travoprost—Rash—Clonazepam—epilepsy syndrome	0.00026	0.000348	CcSEcCtD
Travoprost—Dermatitis—Clonazepam—epilepsy syndrome	0.00026	0.000348	CcSEcCtD
Travoprost—Arthralgia—Gabapentin—epilepsy syndrome	0.00026	0.000348	CcSEcCtD
Travoprost—Chest pain—Gabapentin—epilepsy syndrome	0.00026	0.000348	CcSEcCtD
Travoprost—Myalgia—Gabapentin—epilepsy syndrome	0.00026	0.000348	CcSEcCtD
Travoprost—Nausea—Felbamate—epilepsy syndrome	0.000259	0.000348	CcSEcCtD
Travoprost—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000259	0.000347	CcSEcCtD
Travoprost—Fatigue—Valproic Acid—epilepsy syndrome	0.000259	0.000347	CcSEcCtD
Travoprost—Anxiety—Gabapentin—epilepsy syndrome	0.000259	0.000347	CcSEcCtD
Travoprost—Dizziness—Carbamazepine—epilepsy syndrome	0.000258	0.000346	CcSEcCtD
Travoprost—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000258	0.000346	CcSEcCtD
Travoprost—Headache—Clonazepam—epilepsy syndrome	0.000258	0.000346	CcSEcCtD
Travoprost—Rash—Phenytoin—epilepsy syndrome	0.000258	0.000346	CcSEcCtD
Travoprost—Mental disorder—Topiramate—epilepsy syndrome	0.000258	0.000346	CcSEcCtD
Travoprost—Dermatitis—Phenytoin—epilepsy syndrome	0.000258	0.000346	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000258	0.000345	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AVP—epilepsy syndrome	0.000258	0.00102	CbGpPWpGaD
Travoprost—Rash—Oxcarbazepine—epilepsy syndrome	0.000257	0.000344	CcSEcCtD
Travoprost—Pain—Valproic Acid—epilepsy syndrome	0.000257	0.000344	CcSEcCtD
Travoprost—Constipation—Valproic Acid—epilepsy syndrome	0.000257	0.000344	CcSEcCtD
Travoprost—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000257	0.000344	CcSEcCtD
Travoprost—Headache—Phenytoin—epilepsy syndrome	0.000256	0.000344	CcSEcCtD
Travoprost—Erythema—Topiramate—epilepsy syndrome	0.000256	0.000344	CcSEcCtD
Travoprost—Discomfort—Gabapentin—epilepsy syndrome	0.000256	0.000344	CcSEcCtD
Travoprost—Headache—Oxcarbazepine—epilepsy syndrome	0.000255	0.000342	CcSEcCtD
Travoprost—Nausea—Zonisamide—epilepsy syndrome	0.000254	0.00034	CcSEcCtD
Travoprost—Dry mouth—Gabapentin—epilepsy syndrome	0.000254	0.00034	CcSEcCtD
Travoprost—Hypotension—Pregabalin—epilepsy syndrome	0.000254	0.00034	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000252	0.000994	CbGpPWpGaD
Travoprost—Dysgeusia—Topiramate—epilepsy syndrome	0.000251	0.000336	CcSEcCtD
Travoprost—Dizziness—Lamotrigine—epilepsy syndrome	0.00025	0.000335	CcSEcCtD
Travoprost—Oedema—Gabapentin—epilepsy syndrome	0.000249	0.000333	CcSEcCtD
Travoprost—Back pain—Topiramate—epilepsy syndrome	0.000248	0.000332	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CHRM2—epilepsy syndrome	0.000247	0.000975	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000247	0.000975	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000247	0.000975	CbGpPWpGaD
Travoprost—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000247	0.000331	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000247	0.000331	CcSEcCtD
Travoprost—Infection—Gabapentin—epilepsy syndrome	0.000247	0.000331	CcSEcCtD
Travoprost—Rash—Carbamazepine—epilepsy syndrome	0.000246	0.00033	CcSEcCtD
Travoprost—Dermatitis—Carbamazepine—epilepsy syndrome	0.000246	0.00033	CcSEcCtD
Travoprost—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000245	0.000329	CcSEcCtD
Travoprost—Nausea—Clonazepam—epilepsy syndrome	0.000245	0.000328	CcSEcCtD
Travoprost—Headache—Carbamazepine—epilepsy syndrome	0.000245	0.000328	CcSEcCtD
Travoprost—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000244	0.000327	CcSEcCtD
Travoprost—Nausea—Phenytoin—epilepsy syndrome	0.000243	0.000326	CcSEcCtD
Travoprost—Tachycardia—Gabapentin—epilepsy syndrome	0.000243	0.000325	CcSEcCtD
Travoprost—Dyspnoea—Pregabalin—epilepsy syndrome	0.000242	0.000324	CcSEcCtD
Travoprost—Nausea—Oxcarbazepine—epilepsy syndrome	0.000242	0.000324	CcSEcCtD
Travoprost—Vision blurred—Topiramate—epilepsy syndrome	0.000242	0.000324	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CDC42—epilepsy syndrome	0.000242	0.000953	CbGpPWpGaD
Travoprost—Skin disorder—Gabapentin—epilepsy syndrome	0.000242	0.000324	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GABBR1—epilepsy syndrome	0.000241	0.000949	CbGpPWpGaD
Travoprost—Rash—Lamotrigine—epilepsy syndrome	0.000238	0.000319	CcSEcCtD
Travoprost—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000238	0.000319	CcSEcCtD
Travoprost—Dermatitis—Lamotrigine—epilepsy syndrome	0.000238	0.000319	CcSEcCtD
Travoprost—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000237	0.000318	CcSEcCtD
Travoprost—Headache—Lamotrigine—epilepsy syndrome	0.000237	0.000317	CcSEcCtD
Travoprost—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000234	0.000314	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AVP—epilepsy syndrome	0.000234	0.000922	CbGpPWpGaD
Travoprost—Fatigue—Pregabalin—epilepsy syndrome	0.000234	0.000313	CcSEcCtD
Travoprost—Hypotension—Gabapentin—epilepsy syndrome	0.000232	0.000311	CcSEcCtD
Travoprost—Nausea—Carbamazepine—epilepsy syndrome	0.000232	0.000311	CcSEcCtD
Travoprost—Pain—Pregabalin—epilepsy syndrome	0.000232	0.000311	CcSEcCtD
Travoprost—Constipation—Pregabalin—epilepsy syndrome	0.000232	0.000311	CcSEcCtD
Travoprost—Malaise—Topiramate—epilepsy syndrome	0.000231	0.00031	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HRH3—epilepsy syndrome	0.000231	0.00091	CbGpPWpGaD
Travoprost—Vertigo—Topiramate—epilepsy syndrome	0.00023	0.000309	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—OPRM1—epilepsy syndrome	0.000227	0.000895	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000227	0.000304	CcSEcCtD
Travoprost—Palpitations—Topiramate—epilepsy syndrome	0.000227	0.000304	CcSEcCtD
Travoprost—Nausea—Lamotrigine—epilepsy syndrome	0.000224	0.000301	CcSEcCtD
Travoprost—Cough—Topiramate—epilepsy syndrome	0.000224	0.0003	CcSEcCtD
Travoprost—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000224	0.0003	CcSEcCtD
Travoprost—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000222	0.000297	CcSEcCtD
Travoprost—Dyspnoea—Gabapentin—epilepsy syndrome	0.000222	0.000297	CcSEcCtD
Travoprost—Hypertension—Topiramate—epilepsy syndrome	0.000221	0.000297	CcSEcCtD
Travoprost—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000221	0.000296	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000219	0.000864	CbGpPWpGaD
Travoprost—Dyspepsia—Gabapentin—epilepsy syndrome	0.000219	0.000293	CcSEcCtD
Travoprost—Arthralgia—Topiramate—epilepsy syndrome	0.000218	0.000293	CcSEcCtD
Travoprost—Chest pain—Topiramate—epilepsy syndrome	0.000218	0.000293	CcSEcCtD
Travoprost—Myalgia—Topiramate—epilepsy syndrome	0.000218	0.000293	CcSEcCtD
Travoprost—Anxiety—Topiramate—epilepsy syndrome	0.000218	0.000292	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000217	0.000291	CcSEcCtD
Travoprost—Discomfort—Topiramate—epilepsy syndrome	0.000216	0.000289	CcSEcCtD
Travoprost—Asthenia—Valproic Acid—epilepsy syndrome	0.000215	0.000288	CcSEcCtD
Travoprost—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000215	0.000288	CcSEcCtD
Travoprost—Fatigue—Gabapentin—epilepsy syndrome	0.000214	0.000287	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCR3—epilepsy syndrome	0.000214	0.000846	CbGpPWpGaD
Travoprost—Abdominal pain—Pregabalin—epilepsy syndrome	0.000214	0.000287	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000214	0.000845	CbGpPWpGaD
Travoprost—Dry mouth—Topiramate—epilepsy syndrome	0.000214	0.000286	CcSEcCtD
Travoprost—Pain—Gabapentin—epilepsy syndrome	0.000213	0.000285	CcSEcCtD
Travoprost—Constipation—Gabapentin—epilepsy syndrome	0.000213	0.000285	CcSEcCtD
Travoprost—Pruritus—Valproic Acid—epilepsy syndrome	0.000212	0.000284	CcSEcCtD
Travoprost—Oedema—Topiramate—epilepsy syndrome	0.000209	0.00028	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NPY—epilepsy syndrome	0.000209	0.000824	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000209	0.000824	CbGpPWpGaD
Travoprost—Infection—Topiramate—epilepsy syndrome	0.000208	0.000279	CcSEcCtD
Travoprost—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000205	0.000275	CcSEcCtD
Travoprost—Nervous system disorder—Topiramate—epilepsy syndrome	0.000205	0.000275	CcSEcCtD
Travoprost—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000205	0.000275	CcSEcCtD
Travoprost—Tachycardia—Topiramate—epilepsy syndrome	0.000204	0.000274	CcSEcCtD
Travoprost—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000203	0.000273	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—AGT—epilepsy syndrome	0.000203	0.000802	CbGpPWpGaD
Travoprost—Skin disorder—Topiramate—epilepsy syndrome	0.000203	0.000272	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CCL3—epilepsy syndrome	0.000202	0.000795	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CXCL2—epilepsy syndrome	0.000202	0.000795	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HSPB1—epilepsy syndrome	0.000202	0.000795	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CRH—epilepsy syndrome	0.000202	0.000795	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—OXT—epilepsy syndrome	0.000202	0.000795	CbGpPWpGaD
Travoprost—Hypersensitivity—Pregabalin—epilepsy syndrome	0.0002	0.000268	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCR5—epilepsy syndrome	0.000199	0.000784	CbGpPWpGaD
Travoprost—Dizziness—Valproic Acid—epilepsy syndrome	0.000198	0.000266	CcSEcCtD
Travoprost—Abdominal pain—Gabapentin—epilepsy syndrome	0.000197	0.000263	CcSEcCtD
Travoprost—Hypotension—Topiramate—epilepsy syndrome	0.000196	0.000262	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000195	0.000767	CbGpPWpGaD
Travoprost—Asthenia—Pregabalin—epilepsy syndrome	0.000195	0.000261	CcSEcCtD
Travoprost—Pruritus—Pregabalin—epilepsy syndrome	0.000192	0.000257	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000191	0.000255	CcSEcCtD
Travoprost—Rash—Valproic Acid—epilepsy syndrome	0.000189	0.000254	CcSEcCtD
Travoprost—Dermatitis—Valproic Acid—epilepsy syndrome	0.000189	0.000253	CcSEcCtD
Travoprost—Headache—Valproic Acid—epilepsy syndrome	0.000188	0.000252	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000188	0.000741	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TSC1—epilepsy syndrome	0.000187	0.000739	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTK2B—epilepsy syndrome	0.000187	0.000739	CbGpPWpGaD
Travoprost—Dyspnoea—Topiramate—epilepsy syndrome	0.000187	0.00025	CcSEcCtD
Travoprost—Diarrhoea—Pregabalin—epilepsy syndrome	0.000186	0.000249	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—AGT—epilepsy syndrome	0.000185	0.000728	CbGpPWpGaD
Travoprost—Dyspepsia—Topiramate—epilepsy syndrome	0.000184	0.000247	CcSEcCtD
Travoprost—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000183	0.000246	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NTRK2—epilepsy syndrome	0.000182	0.000719	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR2—epilepsy syndrome	0.000182	0.000719	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SST—epilepsy syndrome	0.000182	0.000719	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DUSP6—epilepsy syndrome	0.000181	0.000713	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000181	0.000242	CcSEcCtD
Travoprost—Fatigue—Topiramate—epilepsy syndrome	0.00018	0.000242	CcSEcCtD
Travoprost—Dizziness—Pregabalin—epilepsy syndrome	0.000179	0.00024	CcSEcCtD
Travoprost—Constipation—Topiramate—epilepsy syndrome	0.000179	0.00024	CcSEcCtD
Travoprost—Pain—Topiramate—epilepsy syndrome	0.000179	0.00024	CcSEcCtD
Travoprost—Asthenia—Gabapentin—epilepsy syndrome	0.000178	0.000239	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000178	0.000704	CbGpPWpGaD
Travoprost—Nausea—Valproic Acid—epilepsy syndrome	0.000178	0.000239	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PLAT—epilepsy syndrome	0.000178	0.000701	CbGpPWpGaD
Travoprost—Pruritus—Gabapentin—epilepsy syndrome	0.000176	0.000236	CcSEcCtD
Travoprost—Feeling abnormal—Topiramate—epilepsy syndrome	0.000172	0.000231	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CXCL12—epilepsy syndrome	0.000171	0.000676	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000171	0.000676	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—POMC—epilepsy syndrome	0.000171	0.000675	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000171	0.000229	CcSEcCtD
Travoprost—Rash—Pregabalin—epilepsy syndrome	0.000171	0.000229	CcSEcCtD
Travoprost—Dermatitis—Pregabalin—epilepsy syndrome	0.000171	0.000229	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000171	0.000673	CbGpPWpGaD
Travoprost—Diarrhoea—Gabapentin—epilepsy syndrome	0.00017	0.000228	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—IL6ST—epilepsy syndrome	0.00017	0.00067	CbGpPWpGaD
Travoprost—Headache—Pregabalin—epilepsy syndrome	0.00017	0.000228	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—CNR1—epilepsy syndrome	0.000168	0.000664	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUNB—epilepsy syndrome	0.000168	0.000664	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PLCB1—epilepsy syndrome	0.000168	0.000661	CbGpPWpGaD
Travoprost—Abdominal pain—Topiramate—epilepsy syndrome	0.000165	0.000222	CcSEcCtD
Travoprost—Dizziness—Gabapentin—epilepsy syndrome	0.000165	0.00022	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HTR7—epilepsy syndrome	0.000164	0.000647	CbGpPWpGaD
Travoprost—Nausea—Pregabalin—epilepsy syndrome	0.000161	0.000216	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HBEGF—epilepsy syndrome	0.000159	0.000628	CbGpPWpGaD
Travoprost—Rash—Gabapentin—epilepsy syndrome	0.000157	0.00021	CcSEcCtD
Travoprost—Dermatitis—Gabapentin—epilepsy syndrome	0.000157	0.00021	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AKT3—epilepsy syndrome	0.000156	0.000617	CbGpPWpGaD
Travoprost—Headache—Gabapentin—epilepsy syndrome	0.000156	0.000209	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—POMC—epilepsy syndrome	0.000155	0.000613	CbGpPWpGaD
Travoprost—Hypersensitivity—Topiramate—epilepsy syndrome	0.000154	0.000207	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—ADAM10—epilepsy syndrome	0.000153	0.000602	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL2—epilepsy syndrome	0.000152	0.0006	CbGpPWpGaD
Travoprost—Asthenia—Topiramate—epilepsy syndrome	0.00015	0.000201	CcSEcCtD
Travoprost—Pruritus—Topiramate—epilepsy syndrome	0.000148	0.000198	CcSEcCtD
Travoprost—Nausea—Gabapentin—epilepsy syndrome	0.000148	0.000198	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—S100B—epilepsy syndrome	0.000145	0.00057	CbGpPWpGaD
Travoprost—Diarrhoea—Topiramate—epilepsy syndrome	0.000143	0.000192	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SOCS3—epilepsy syndrome	0.000143	0.000564	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CDC42—epilepsy syndrome	0.000143	0.000563	CbGpPWpGaD
Travoprost—Dizziness—Topiramate—epilepsy syndrome	0.000138	0.000185	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—AVP—epilepsy syndrome	0.000138	0.000545	CbGpPWpGaD
Travoprost—Rash—Topiramate—epilepsy syndrome	0.000132	0.000177	CcSEcCtD
Travoprost—Dermatitis—Topiramate—epilepsy syndrome	0.000132	0.000177	CcSEcCtD
Travoprost—Headache—Topiramate—epilepsy syndrome	0.000131	0.000176	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HES1—epilepsy syndrome	0.000131	0.000515	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FYN—epilepsy syndrome	0.000127	0.000501	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—H2AFX—epilepsy syndrome	0.000127	0.000499	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MEF2C—epilepsy syndrome	0.000126	0.000498	CbGpPWpGaD
Travoprost—Nausea—Topiramate—epilepsy syndrome	0.000124	0.000167	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000122	0.000482	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NGF—epilepsy syndrome	0.000121	0.000476	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCR5—epilepsy syndrome	0.000118	0.000463	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR2A—epilepsy syndrome	0.000115	0.000453	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TSC2—epilepsy syndrome	0.000109	0.000431	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AGT—epilepsy syndrome	0.000109	0.00043	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOE—epilepsy syndrome	0.000107	0.000421	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—KDR—epilepsy syndrome	0.000105	0.000413	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCB—epilepsy syndrome	0.000101	0.000397	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6ST—epilepsy syndrome	0.0001	0.000396	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—POMC—epilepsy syndrome	9.18e-05	0.000362	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL2—epilepsy syndrome	8.99e-05	0.000354	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FGF2—epilepsy syndrome	8.12e-05	0.00032	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RELA—epilepsy syndrome	7.54e-05	0.000297	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MTOR—epilepsy syndrome	7.39e-05	0.000291	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT1—epilepsy syndrome	6.86e-05	0.000271	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CASP3—epilepsy syndrome	6.8e-05	0.000268	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—JUN—epilepsy syndrome	6.61e-05	0.00026	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—epilepsy syndrome	6.43e-05	0.000253	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT1—epilepsy syndrome	6.23e-05	0.000246	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SRC—epilepsy syndrome	5.92e-05	0.000234	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—VEGFA—epilepsy syndrome	5.77e-05	0.000227	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT1—epilepsy syndrome	3.68e-05	0.000145	CbGpPWpGaD
